Non-Hodgkin lymphoma (NHL) Treatment in India

What is Non-Hodgkin lymphoma (NHL)?

Non-Hodgkin lymphoma is a kind of cancer affecting the lymphatic system. The lymphatic system comprises organs, glands, tube-like channels, and lymph node clusters. It is a component of the body's germ-fighting immune system.

Non-Hodgkin lymphoma develops when germ-fighting cells in the lymphatic system become out of control. Tumors are growths that cells can generate throughout the body.

What is the Importance of Timely Treatment?

Non-Hodgkin lymphoma (NHL) should be treated immediately to improve patient outcomes. Early management helps to keep the condition from developing to later stages, which can be more challenging to treat.

NHL has considerably better survival rates when discovered and treated early since patients are more likely to respond successfully to medicines, including chemotherapy, immunotherapy, and targeted treatments.

Delays in therapy might result in problems such as organ damage and increased tumour growth, lowering the likelihood of successful management.

Timely NHL treatment increases the chances of remission, reduces complications, and improves overall quality of life.

What are the Common Symptoms of Non-Hodgkin lymphoma (NHL)?

Non-Hodgkin lymphoma symptoms may include the following:

• Swollen lymph nodes in the neck, armpits, or groin
• Persistent exhaustion
• Chest discomfort
• Cough
• Difficulty breathing (dyspnea)
• Abdominal discomfort or edema
• Symptoms may include feeling full despite not having eaten
• Unexplained temperature.
• Drenching night sweats.
• Unexplained weight loss

Types of Non-Hodgkin lymphoma (NHL)

Non-Hodgkin lymphoma can be classified into over 70 different subgroups. Healthcare practitioners categorise them according to the type of lymphocyte affected:

• B cell lymphoma: B cells are a type of lymphocyte that helps fight infection. B cells produce antibodies against foreign invaders. B cells are responsible for the vast majority of non-Hodgkin lymphomas. Non-Hodgkin lymphoma subtypes involving B cells include diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and Burkitt lymphoma.
• T cell lymphoma: T cells are lymphocytes that destroy foreign invaders directly. Non-Hodgkin lymphoma occurs substantially less frequently in T cells. Peripheral T-cell lymphoma and cutaneous T-cell lymphoma are two T-cell-related non-Hodgkin lymphoma subtypes.

Stages of Non-Hodgkin lymphoma (NHL)

Healthcare providers stage cancer to design treatment strategies and predict prognosis, which is the expected outcome. Non-Hodgkin lymphoma stages are as follows:

• Stage I: Cancer cells are seen in one lymph node or lymphoid organ. Or there is lymphoma in a specific location of a particular organ outside your lymphatic system.
• Stage II: Lymphoma exists in two or more groups of lymph nodes on the same side of (or near) your diaphragm.
• Stage III: Cancer cells are found in lymph node locations above and below your diaphragm or lymph nodes above your diaphragm and in your spleen.
• Stage IV: At least one organ outside your lymph system, such as your liver or lungs, has extensive lymphoma.

Causes, Risk Factors and Complications of Non-Hodgkin lymphoma (NHL)

Causes

• Non-Hodgkin lymphomas develop when your body creates an excess of lymphocytes. These comprise B cells, T cells, and (occasionally) natural killer (NK) cells. Acquired genetic alterations that influence lymphocyte development contribute to the process.
• When lymphocytes mutate, they multiply and eventually become tumours. Usually, cancers begin in your lymph nodes. Because the lymphatic system contacts almost every body region, non-Hodgkin lymphoma frequently spreads to other lymph organs.

Risk Factors

The following factors may increase the risk of non-Hodgkin lymphoma:

• Medicines that reduce immune response: Following an organ transplant, taking immune-modulating medications may increase the risk of non-Hodgkin lymphoma.
• Infection with certain viruses and bacteria: A few infections appear to increase the risk of non-Hodgkin lymphoma.
• Chemicals: Certain chemicals, such as those used to eliminate insects and weeds, can increase the risk of non-Hodgkin lymphoma.
• Older age: Non-Hodgkin lymphoma can develop at any age. However, it is more common among those aged 60 and up.

Complications

Non-Hodgkin lymphoma and its therapies can induce a variety of problems, including:

• Weakened immune system.
• Fertility problems
• Secondary Cancer
• Organ Damage

Latest Research and Technologies in the Treatment of Non-Hodgkin lymphoma (NHL) in India

• In India, the most recent developments in Non-Hodgkin Lymphoma (NHL) treatment focus on improving chemotherapy regimens, such as R-CHOP, while incorporating targeted therapies and investigating novel immunotherapies, such as CAR T cell therapy.
• These novel medicines hold particular promise for people with relapsed or refractory conditions. Ongoing clinical trials are assessing its efficacy in the Indian population.
• Furthermore, stem cell transplantation is regarded as a promising treatment for high-risk patients or those with recurrent NHL, providing hope for better results.

Non-Hodgkin lymphoma (NHL) Prevention Tips

Some preventative tips for non-Hodgkin lymphoma (NHL):

• Prevent exposure to hazardous chemicals.
• Reduce radiation exposure from unneeded medical imaging and workplace settings.
• Improve immunological health by eating a well-balanced diet, exercising regularly, and managing stress.
• Prevent infection.
• To lower the risk of NHL, limit your alcohol consumption.
• To support immune function, eat a nutritious diet that includes fruits, vegetables, and whole grains.
• These steps can help lower risk, but frequent health screenings are necessary for early detection.